Copyright
©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2581-2590
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2581
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2581
Article | Shlomovitz et al[25], 2014 | Gonzalez et al[26], 2017 | Kahaleh et al[27], 2018 | Rodriguez et al[28], 2017 | Rodriguez et al[29], 2018 | Malik et al[30], 2018 | Jacques et al[31], 2017 | Dacha et al[32], 2017 | Mekaroonkamol et al[33], 2018 | Khashab et al[34], 2017 |
n | 7 | 29 | 33 | 47 | 100 | 13 | 20 | 16 | 30 | 30 |
Procedure length (min) | 90-1201 | 47 ± 22 | 77.6 (37-255) | 41.2 ± 28.5 | 33.8 ± 21.6 | 119 ± 23 | 56.5 | 49.7 ± 22.1 | 48.3 ± 16.5 | 72 ± 42 |
Length of stay (mean) | 2.3 | — | 5.4 (1-14) | 1.09 ± 0.6 | 1.3 ± 1.05 | 2.5 ± 1.4 d | 3.75 | 2.46 | 2.4 ± 1.0 | — |
Pre ABX | Yes, IV | Yes, IV | Gentamicin wash | None | None | Gentamicin wash | None | Yes, IV | Yes | Post-Op |
Site of mucosotomy (cm proximal to pylorus) | 5 | 5 | 5-6 | 5 | 4 | 5 | 4-5 | 5 | 5-7 | 5 |
Mucosal entry location | greater curvature in 31, 2 patients lesser curvature. | Greater curvature 19, anterior wall 9, posterior wall 2 | greater curvature | — | 95 lesser curvature, 4 greater, 1 posterior | greater curvature | greater curvature | lesser curvature | — | — |
Lift Solution | 5-10 mL 1: 10000 Epi | — | 5 mL methylene blue and 500 saline mixture | methylene blue6 | methylene blue | Not used | glycerol | 5 mL methylene blue and 500 saline mixture | — | saline and 0.25% indigo carmine solution or methylene blue solution2 |
Size of mucsoal incision (cm) | 1-2 | — | 2 | 2 | — | — | — | 2 | 3-4 | 1.5-2 |
Knife Used | T Knife | Triangle knife | Hybrid knife or IT2 | Triangular knife | triangle tip knife | I-Type Hybrid knife | T-Type for initial incision, Hybrid knife for tunnel, Hook Knife for myotomy | Hook Knife or I-type knife | I hybrid knife | Triangular tip knife |
Size of myotomy mean (cm) | 2 | 3.34 (2-6) | — | — | 3.5 ± 0.8 | — | 3.94 | 2-3 | — | |
Upper GI series | — | — | — | POD 1 | POD 1 | POD 1-2 | — | POD 1 | POD 1 | POD 1 |
Use of PPI | BID PPI for 6 wk | BID PPI for 4 wk | — | PPI BID for 4 wk w/Sucralfate | BID PPI and QID sucralfate for at least 2 wk | — | — | — | BID for 8 wk | |
Antibiotics on discharge | — | — | — | — | — | — | — | 5 d oral Abx | — | IV Abx following procedure |
Dietary restrictions | Clear liquid immediately, pureed/soft diet for 2 wk, | observed for 1 d NPO, then advanced to clears, observed for 5 d and sent home on | Clear liquid diet 2-3 d, advanced to gastroparetic diet | advanced to clears with liquid diet for 2 wk | liquid diet for 2-4 wk | Clear liquid diet, advance as tolerated | Liquid diet day after procedure | advance to liquid after upper GI and ADAT | clear liquid and advanced diet over 4 wk course | liquid diet started then advanced to soft then to gastroparetic diet |
Total of major post operative complications | 4/7 | 5/29 | 1/33 | 0/47 | 10/100 | 1/13 | 3/20 | 0/16 | 1 | 2/30 |
- Citation: Podboy A, Hwang JH, Nguyen LA, Garcia P, Zikos TA, Kamal A, Triadafilopoulos G, Clarke JO. Gastric per-oral endoscopic myotomy: Current status and future directions. World J Gastroenterol 2019; 25(21): 2581-2590
- URL: https://www.wjgnet.com/1007-9327/full/v25/i21/2581.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i21.2581